Skip this navigation
TECHNOLOGY | 18.04.2023

Gallium Combines Diagnosis and Therapy of Tumors

In der Kontrollkammer diskutieren Arzt und Radiologe Diagnostik während des Analyseverfahrens und Monitore, die Ergebnisse von Gehirnscans zeigen, im Hintergrund durchläuft der Patient MRI- oder CT-Scan-Verfahren.

The radiopharmacy department of the Zentralklinik in Bad Berka (Thuringia) has received manufacturing authorization for three gallium-based radiopharmaceutical products. The innovative therapeutics are based on the latest theranostic principles, meaning they combine diagnosis and therapy.

For example, GA68-PSMA11, one of the three products, is used in radioligand therapy, a nuclear medicine treatment for prostate cancer. GA68-DOTATOC, by contrast, is used for neuroendocrine tumors.

The Zentralklinik in Bad Berka is recognized as a center of excellence and ranks among the world’s leading centers in the treatment of rare tumor forms. Approximately 3,300 patients, including several hundred patients from abroad, benefit annually from the facility’s highly qualified team and its medical products manufactured to the highest standards.

Gallium is a central component of these products, and you can invest in it as a physical asset. This provides you with the opportunity for high returns, alongside tax-free purchase and tax-free gains after a holding period of one year.

Contact

You can also reach us by phone: Monday to Friday from 10:00 to 17:00.

+49 30 20898486-0

Data Protection Required

Weitere Beiträge

  •   
  •   
  •